Proposed Data Collections Submitted for Public Comment and Recommendations, 35392-35393 [E8-14154]
Download as PDF
<![CDATA[
35392
Federal Register / Vol. 73, No. 121 / Monday, June 23, 2008 / Notices
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
National Program of Cancer Registries
Program Evaluation Instrument (NPCR–
PEI)—Revision—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
CDC is responsible for administering
and monitoring the National Program of
Cancer Registries (NPCR). The NPCR
provides technical assistance and
funding and sets program standards to
assure that complete local, state,
regional, and national cancer incidence
data are available for national and state
cancer control and prevention activities
and health planning activities. As of
2008, CDC supports 49 populationbased central cancer registries (CCR) in
(12) survey feedback. Examples of
information that can be obtained from
various questions include, but are not
limited to: (1) Number of filled full-time
staff positions by position
responsibility; (2) legislation protecting
the confidentiality of CCR data; (3) data
quality control activities; (4) data
collection activities as they relate to
achieving NPCR standards for data
completeness; and (5) whether or not
registry data are used for comprehensive
cancer control programs, needs
assessment/program planning, clinical
studies, or incidence and mortality
estimates.
The NPCR–PEI is needed in order to
receive, process, evaluate, aggregate,
and disseminate NPCR program
information. The information is used by
CDC and the NPCR-funded registries to
monitor progress toward meeting
established program standards, goals,
and objectives; to evaluate various
attributes of the registries funded by
NPCR; and to respond to data inquiries
made by CDC and other agencies of the
federal government.
CDC requests OMB approval for a
period of three years to collect
information in the summer of 2009 and
the summer of 2011. There are no costs
to respondents except their time.
The estimated annualized burden
hours are summarized in the table
below.
45 states, two territories, the District of
Columbia, and the Pacific Islands. The
National Cancer Institute supports the
operations of CCRs in the five remaining
states.
Cancer registries currently submit
information about registry operations to
CDC on an annual basis via a secure,
web-based Annual Program Evaluation
Instrument (APEI) (OMB 0920–0706,
exp. 12/31/2008). During the next OMB
approval period, CDC proposes to
change the data collection frequency
from annual to every other year, with
data collection occurring only in oddnumbered years. This change will
reduce burden to respondents. The
project title and the instrument will be
revised to reflect the change in data
collection frequency (from National
Program of Cancer Registries Annual
Program Evaluation Instrument (NPCR–
APEI) to National Program of Cancer
Registries Program Evaluation
Instrument (NPCR–PEI)).
The Program Evaluation Instrument
(NCPR–PEI) includes questions about
the following categories of registry
operations: (1) Staffing, (2) legislation,
(3) administration, (4) reporting
completeness, (5) data exchange, (6)
data content and format, (7) data quality
assurance, (8) data use, (9) collaborative
relationships, (10) advanced activities,
(11) ‘‘success stories’’ that summarize
ways in which CCR data are used, and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
NPCR Grantees ...............................................................................................
Dated: June 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–14152 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mmaher on PROD1PC70 with NOTICES
[60Day–08–08BE]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
VerDate Aug<31>2005
01:51 Jun 21, 2008
Jkt 214001
33
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
PO 00000
Frm 00027
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
1
Total burden
(in hours)
1.5
50
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Chronic Hepatitis Cohort Study
(CHeCS)—New—National Center for
HIV, Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Approximately 3.2 million Americans
are chronically infected with hepatitis C
virus and 1.25 million Americans are
E:\FR\FM\23JNN1.SGM
23JNN1
35393
Federal Register / Vol. 73, No. 121 / Monday, June 23, 2008 / Notices
chronically infected with hepatitis B
virus. Each year, there are
approximately 8,000–10,000 hepatitis C
virus infection related deaths and
3,000–5,000 hepatitis B virus infection
related deaths.
Current surveillance activities are not
designed to monitor long-term outcomes
and merely report diagnosed cases of
hepatitis B and hepatitis C virus
infections. In order to investigate longterm effects of new therapies for chronic
viral hepatitis B and C infections, we
need longitudinal observational cohorts
of persons chronically infected with
hepatitis B and/or C virus. Information
from longitudinal cohorts of patients
with chronic hepatitis B and C virus
infection will provide an understanding
of the spectrum and natural history and,
the public health impact of chronic
hepatitis disease.
adherence to prescribed therapy, which
is essential in order to be able to
correctly interpret clinical outcomes
data. These data will be used to describe
the spectrum and natural history of
disease associated with chronic
hepatitis B and C virus infection, to
determine the extent of health burden
and mortality related to chronic viral
hepatitis, describe the characteristics of
persons in care for chronic viral
hepatitis infection, describe access to
and effectiveness of recommended
preventive and therapeutic
interventions, and evaluate ongoing risk
behaviors and their impact on health
outcomes.
Participation in this data collection is
voluntary and there is no cost to
respondents other than their time.
The proposed project will establish a
longitudinal observational cohort of
patients with chronic viral hepatitis in
one or more clinical centers. A patient
behavior questionnaire will be included
with the clinical information that
physicians routinely collect when
evaluating and examining a patient (i.e.
during physician-patient interactions).
The information linking behaviors with
the clinical information from this
longitudinal study will enable better
care and management of persons with
chronic hepatitis B and C virus
infections and reduce hepatitis-related
mortality.
The total annual burden for this
project is expected to be 500 hours. The
information to be collected in the
patient behavior questionnaire includes
demographic data, alcohol or drug use,
access to care, quality of life, and
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Respondents
Patients with chronic hepatitis B or C virus infection ......................................
Dated: June 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–14154 Filed 6–20–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and ControlSpecial
Emphasis Panel (SEP): Health
Promotion and Disease Prevention
Research Centers: FY08 Special
Interest Project Competitive
Supplements, Program Announcement
Number (PA) DP 08–002
mmaher on PROD1PC70 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting:
01:51 Jun 21, 2008
Jkt 214001
1000
1
Average burden per
response
(in hours)
Total burden
(in hours)
30/60
500
Matters to be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Health Promotion and Disease
Prevention Research Centers: FY08 Special
Interest Project Competitive Supplements,
PA DP 08–002.’’
Contact Person for More Information: K.
Ann Berry, Senior Scientist, CDC, 1600
Clifton Road, NE., Mailstop E20, Atlanta, GA
30333, Telephone (404) 498–2503.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 16, 2008.
Elaine L. Baker,
Director, Management Analysis and Services
Office,Centers for Disease Control and
Prevention.
[FR Doc. E8–14082 Filed 6–20–08; 8:45 am]
Time and Date: 8 a.m.–5 p.m., July 10,
2008 (Closed).
Place: Grand Hyatt Atlanta, 3300 Peachtree
Road, NE., Atlanta, GA 30305, Telephone:
(404) 237–1234.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications received in
response to ‘‘Spina Bifida Patient Registry
Demonstration Project (U01), PA DP 08–
001.’’
For More Information Contact: Gwendolyn
Cattledge, Deputy Associate Director for
Science, CDC, 1600 Clifton Road, NE.,
BILLING CODE 4163–18–P
Time and Dates: 8 a.m.–5 p.m., July 9,
2008 (Closed).8 a.m.–5 p.m., July 10, 2008
(Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c)(4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
VerDate Aug<31>2005
Number of
responses per
respondent
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Spina Bifida
Patient Registry Demonstration Project
(U01), Program Announcement
Number (PA) DP 08–001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
E:\FR\FM\23JNN1.SGM
23JNN1
]]>Agencies
[Federal Register Volume 73, Number 121 (Monday, June 23, 2008)]
[Notices]
[Pages 35392-35393]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-14154]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-08-08BE]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Chronic Hepatitis Cohort Study (CHeCS)--New--National Center for
HIV, Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Approximately 3.2 million Americans are chronically infected with
hepatitis C virus and 1.25 million Americans are
[[Page 35393]]
chronically infected with hepatitis B virus. Each year, there are
approximately 8,000-10,000 hepatitis C virus infection related deaths
and 3,000-5,000 hepatitis B virus infection related deaths.
Current surveillance activities are not designed to monitor long-
term outcomes and merely report diagnosed cases of hepatitis B and
hepatitis C virus infections. In order to investigate long-term effects
of new therapies for chronic viral hepatitis B and C infections, we
need longitudinal observational cohorts of persons chronically infected
with hepatitis B and/or C virus. Information from longitudinal cohorts
of patients with chronic hepatitis B and C virus infection will provide
an understanding of the spectrum and natural history and, the public
health impact of chronic hepatitis disease.
The proposed project will establish a longitudinal observational
cohort of patients with chronic viral hepatitis in one or more clinical
centers. A patient behavior questionnaire will be included with the
clinical information that physicians routinely collect when evaluating
and examining a patient (i.e. during physician-patient interactions).
The information linking behaviors with the clinical information from
this longitudinal study will enable better care and management of
persons with chronic hepatitis B and C virus infections and reduce
hepatitis-related mortality.
The total annual burden for this project is expected to be 500
hours. The information to be collected in the patient behavior
questionnaire includes demographic data, alcohol or drug use, access to
care, quality of life, and adherence to prescribed therapy, which is
essential in order to be able to correctly interpret clinical outcomes
data. These data will be used to describe the spectrum and natural
history of disease associated with chronic hepatitis B and C virus
infection, to determine the extent of health burden and mortality
related to chronic viral hepatitis, describe the characteristics of
persons in care for chronic viral hepatitis infection, describe access
to and effectiveness of recommended preventive and therapeutic
interventions, and evaluate ongoing risk behaviors and their impact on
health outcomes.
Participation in this data collection is voluntary and there is no
cost to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Patients with chronic hepatitis B or C virus 1000 1 30/60 500
infection......................................
----------------------------------------------------------------------------------------------------------------
Dated: June 13, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E8-14154 Filed 6-20-08; 8:45 am]
BILLING CODE 4163-18-P
